| 000 | 01703 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512123318.0 | ||
| 264 | 0 | _c19730222 | |
| 008 | 197302s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI107161 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldsmith, R S | |
| 245 | 0 | 0 |
_aEtiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cJan 1973 |
||
| 300 |
_a173-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Diseases _xetiology |
| 650 | 0 | 4 |
_aCalcium _xadministration & dosage |
| 650 | 0 | 4 |
_aCattle _ximmunology |
| 650 | 0 | 4 | _aChromatography, Gel |
| 650 | 0 | 4 |
_aGluconates _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperparathyroidism _xetiology |
| 650 | 0 | 4 | _aImmune Sera |
| 650 | 0 | 4 | _aIodine Isotopes |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xtherapy |
| 650 | 0 | 4 | _aMethods |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 |
_aParathyroid Glands _xphysiopathology |
| 650 | 0 | 4 |
_aParathyroid Hormone _xblood |
| 650 | 0 | 4 |
_aPhosphorus _xblood |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 650 | 0 | 4 | _aSpectrophotometry, Atomic |
| 650 | 0 | 4 |
_aSwine _ximmunology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aFurszyfer, J | |
| 700 | 1 | _aJohnson, W J | |
| 700 | 1 | _aFournier, A E | |
| 700 | 1 | _aSizemore, G W | |
| 700 | 1 | _aArnaud, C D | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 52 _gno. 1 _gp. 173-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI107161 _zAvailable from publisher's website |
| 999 |
_c4737736 _d4737736 |
||